# C_2020280EN.01002101.xml

| 25.8.2020 | EN | Official Journal of the European Union | C 280/21 |
| --- | --- | --- | --- |

25.8.2020

EN

Official Journal of the European Union

C 280/21

---

Prior notification of a concentration

(Case M.9930 – LGP/TPG/WellSky)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 280/09)

1.

This notification concerns the following undertakings:

| — | Leonard Green & Partners, L.P. (‘LGP’, USA), |
| --- | --- |

—

Leonard Green & Partners, L.P. (‘LGP’, USA),

| — | TPG Capital (‘TPG’, USA), |
| --- | --- |

—

TPG Capital (‘TPG’, USA),

| — | WellSky Corporation (‘WellSky’, USA). |
| --- | --- |

—

WellSky Corporation (‘WellSky’, USA).

LPG and TPG will acquire joint control within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation over the whole of WellSky. TPG currently enjoys sole control over WellSky.

The concentration is accomplished by way of purchase of shares.

2.

| — | for LGP: private equity investment firm, primarily investing in companies providing services, including consumer, business, and healthcare services, as well as retail, distribution, and industrials, |
| --- | --- |

—

for LGP: private equity investment firm, primarily investing in companies providing services, including consumer, business, and healthcare services, as well as retail, distribution, and industrials,

| — | for TPG: private investment firm that manages a family of funds that invest in a variety of companies through acquisitions and corporate restructurings, |
| --- | --- |

—

for TPG: private investment firm that manages a family of funds that invest in a variety of companies through acquisitions and corporate restructurings,

| — | for WellSky: provider of specialty healthcare software (Software as a Service, ‘SaaS’ and other software platforms) for managing clinical, financial and administrative work flows. In the EEA, WellSky only markets software solutions, which address medication management and chemotherapy management software. |
| --- | --- |

—

for WellSky: provider of specialty healthcare software (Software as a Service, ‘SaaS’ and other software platforms) for managing clinical, financial and administrative work flows. In the EEA, WellSky only markets software solutions, which address medication management and chemotherapy management software.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9930 – LGP/TPG/WellSky

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---